mTOR, metabolism, and the immune response in HPV-positive head and neck squamous cell cancer
Extensive preclinical studies have identified mammalian target of rapamycin (mTOR) activation as a frequent molecular signature underlying head and neck squamous cell carcinoma (HNSCC), including the distinct clinical subtype that is human papillomavirus (HPV) related, and have demonstrated the pote...
Guardado en:
Autores principales: | Joseph D. Coppock, John H. Lee |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
KeAi Communications Co., Ltd.
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6ea55a55dc194ba9983b051ef865fc79 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
High risk cutaneous squamous cell carcinoma of the head and neck
por: Stephen Y. Kang, et al.
Publicado: (2016) -
Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Moaz M. Choudhary, et al.
Publicado: (2016) -
Current state and future of photodynamic therapy for the treatment of head and neck squamous cell carcinoma
por: Christina Mimikos, et al.
Publicado: (2016) -
Novel p53 therapies for head and neck cancer
por: Mario R. Castellanos, et al.
Publicado: (2016) -
Novel therapeutics and emerging technologies in head and neck cancer
por: Theodoros N. Teknos, M.D.
Publicado: (2016)